×
For best experience we recommend to activate Javascript in your browser.
Caldesmon antibody (C-Term)
The Rabbit Monoclonal anti-Caldesmon antibody (Clone 13G23) (ABIN2217378) specifically detects Caldesmon in WB, IF and IP.
The antibody is reactive with Human samples.
Catalog No. ABIN2217378
$860.86
Plus shipping costs $50.00
Delivery in 11 to 17 Business Days
Quick Overview for Caldesmon antibody (C-Term) (ABIN2217378)
Target
See all Caldesmon (CALD1) Antibodies
Caldesmon (CALD1)
(Caldesmon 1 (CALD1))
Reactivity
All reactivities for Caldesmon antibodies
Human
Host
All hosts for Caldesmon antibodies
Rabbit
Clonality
All clonalities for Caldesmon antibodies
Monoclonal
Conjugate
All conjugates for Caldesmon antibodies
This Caldesmon antibody is un-conjugated
Application
All applications for Caldesmon antibodies
Western Blotting (WB), Immunofluorescence (IF), Immunoprecipitation (IP)
Clone
13G23
Product Details anti-Caldesmon Antibody
(hide)
Binding Specificity
All epitopes for Caldesmon antibodies
C-Term
Cross-Reactivity
Human, Monkey, Mouse (Murine), Rat (Rattus)
Cross-Reactivity (Details)
Calculated cross reactivity: Hu Mk Mo Rt
Characteristics
Caldesmon-1 (CAD, CALD1)
Purification
Purified.
Immunogen
Synthetic peptide corresponding to residues near the C-terminal domain of human caldesmon-1.
Isotype
IgG
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working conditions should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Buffer
Supplied in 10 mM sodium HEPES, pH 7.5, 150 mM NaCl, 100 μg/mL BSA, 50 % glycerol and <0.02 % sodium azide.
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
-20 °C
Storage Comment
-20°C
Target Details for Caldesmon
(hide)
Target
Caldesmon (CALD1)
(Caldesmon 1 (CALD1))
Alternative Name
Caldesmon-1
UniProt
Q05682
Pathways
Myometrial Relaxation and Contraction
Recently viewed
(hide)
Chat with us , powered by LiveChat